Skip to Content

Functional Characterization for Germline Variants in Patients with MDS and AML

Germline variants in DDX41, an RNA helicase, can be detected in up to 4% of all newly diagnosed patients with MDS and AML. DDX41 plays a crucial role in various cellular processes. In this MEDtalk, Nikolaj Nitschke presents a study that aims to develop an assay that can functionally characterize individual DDX41 variants, thereby enhancing our understanding of how germline variants in DDX41 affect cellular function.

Nikolaj Nitschke

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top